{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-004898","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.370083+00:00","generated_at":"2026-06-04T00:19:43.676623+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ReShape Lifesciences dismisses RSM, appoints Haskell & White as auditor; prior reports cited going concern doubt","bullets":["Effective April 8, 2024, RSM US LLP dismissed as independent auditor; Haskell & White LLP engaged for FY2024 and interim periods.","RSM's audit reports for FY2023 and FY2022 contained an emphasis-of-matter paragraph regarding substantial doubt about the company's ability to continue as a going concern.","No disagreements with RSM on accounting principles, financial disclosure, or audit scope during FY2023, FY2022, or through the dismissal date.","Previously reported material weaknesses in internal control over financial reporting for FY2023 and FY2022 remain on file."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-004898","json":"https://secwatch.observer/filing/0001558370-24-004898.json","markdown":"https://secwatch.observer/filing/0001558370-24-004898.md","text":"https://secwatch.observer/filing/0001558370-24-004898.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024004898/0001558370-24-004898-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024004898/rsls-20240408x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:19:43.676623+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"57c867b515e2506b63d4acecf83d629fae35829a","claim":"Vyome Holdings, Inc dismissed RSM US LLP as its auditor.","evidence_excerpt":"On April 8, 2024, ReShape Lifesciences Inc. (the “Company”), with the prior approval of the Audit Committee of the Board of Directors, dismissed RSM US LLP (“RSM”) as the Company’s independent registered public accounting firm, effective immediately.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024004898/0001558370-24-004898-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"RSM US LLP"},{"label":"Successor","value":"Haskell & White LLP"}],"fact_type":"auditor_change"},{"claim_id":"e704abfa797d6a19b7262a0ce33b3671d64bae2c","claim":"Vyome Holdings, Inc engaged Haskell & White LLP as its auditor.","evidence_excerpt":"with the prior approval of the Audit Committee, the Company engaged Haskell & White LLP (“Haskell & White”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 and related interim periods.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024004898/0001558370-24-004898-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Haskell & White LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}